At 30 days, bleeding and pacemaker rates were lower than in TRISCEND II, but long-term outcomes are eagerly awaited.

The addition of stenting to usual care reduced symptoms and improved quality of life for patients with the condition after ...

Known for his skills as a clinician and educator, Montorfano contributed much to the interventional cardiology community.

Patients at high risk for pulmonary complications had similar support needs at 90 days with HFNOT or standard oxygen.

Risk-factor control was poorer in female patients, who had a lower likelihood of reaching LDL and physical activity targets.

Among patients with a single CTO lesion, the study found an improvement in health status compared with medical therapy.

The IMPACTS-BP trial showed that SPRINT-like reductions in systolic BP are possible even in tough real-world scenarios.

Kenneth Rosenfield, Erik Klok, and Stavros Konstantinides join Mamas Mamas to discuss ultrasound-facilitated, ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

The benefit of digoxin was driven by reduced risk of new-onset or worsening HF hospitalizations, just like its benefit in ...

The consistent underrepresentation of African populations in clinical studies is a ‘crisis of scientific validity,’ Bamba ...

Hypertension’s burden has continued to rise around the world, with disparities between lower- versus higher-income countries ...